In Medicare negotiation process, HHS sends 1st price offers as industry blasts lack of transparency

Despite litigation and denouncements from the biopharma industry, Medicare price negotiations under the Inflation Reduction Act are rolling on. And today, the government is sending out its first round of offers on affected drugs.